Tsurukawa Shinichiro, Iwanaga Nozomi, Izumi Yasumori, Shirakawa Atsunori, Kawahara Chieko, Shukuwa Tetsuo, Inamoto Miwako, Kawakami Atsushi, Migita Kiyoshi
Department of Rheumatology, Clinical Research Center, NHO Nagasaki Medical Center, Kubara 2-1001-1, Omura 856-8562, Japan.
Department of Pharmacy, Clinical Research Center, NHO Nagasaki Medical Center, Kubara 2-1001-1, Omura 856-8562, Japan.
Case Rep Rheumatol. 2016;2016:4232657. doi: 10.1155/2016/4232657. Epub 2016 Mar 22.
A 56-year-old female with refractory adult-onset Still's disease presented with ocular herpes zoster infection during TCZ treatment. After three days of acyclovir treatment (5 mg/kg), she developed a severe headache and high fever. Viral DNA isolation and cerebral spinal fluid abnormalities led to a herpes zoster meningitis diagnosis. Her meningitis was cured by high doses of intravenous acyclovir (10 mg/kg for 14 days). To our knowledge, this is the first report of meningeal herpes zoster infection in rheumatic diseases under TCZ treatment.
一名56岁患有难治性成人斯蒂尔病的女性在托珠单抗(TCZ)治疗期间出现眼部带状疱疹感染。在接受阿昔洛韦治疗(5mg/kg)三天后,她出现了严重头痛和高热。病毒DNA分离及脑脊液异常导致带状疱疹脑膜炎的诊断。她的脑膜炎通过大剂量静脉注射阿昔洛韦(10mg/kg,持续14天)得以治愈。据我们所知,这是关于在TCZ治疗的风湿性疾病中发生脑膜带状疱疹感染的首例报告。